Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 115 full-time employees. The company went IPO on 2005-07-12. The company operates through two reportable segments: healthcare services and product sales. Its businesses include healthcare, medical technology, manufacturing, research and diagnostics, and products and brands. Its specialized primary health care services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, and others. Its products include Terragenx and ProDip (dietary supplement pouches). Terragenx is a micro-dosing IoNovo Iodine product for all ages and lifestyles. Its medical technologies include telemedicine, and remote patient monitoring.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
08/31/2024
08/31/2023
08/31/2022
08/31/2021
08/31/2020
Revenue
13
13
12
11
9
7
Revenue Growth (YoY)
8%
8%
9%
22%
28.99%
-22%
Cost of Revenue
7
7
7
6
5
4
Gross Profit
5
5
4
4
3
3
Selling, General & Admin
14
14
13
14
8
7
Research & Development
--
--
--
--
--
--
Operating Expenses
14
14
13
14
8
7
Other Non Operating Income (Expenses)
-1
-1
0
0
--
0
Pretax Income
-16
-16
-13
-33
-4
-4
Income Tax Expense
0
0
0
0
0
0
Net Income
-16
-16
-13
-32
-4
-4
Net Income Growth
23%
23%
-59%
700%
0%
--
Shares Outstanding (Diluted)
19.06
18.03
10.16
2.91
2.48
2.3
Shares Change (YoY)
28%
77%
249%
17%
8%
6%
EPS (Diluted)
-0.84
-0.89
-1.29
-11.28
-1.8
-2.13
EPS Growth
-5%
-31%
-88%
527%
-15%
1,083%
Free Cash Flow
-5
-5
-2
-6
-1
0
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
38.46%
38.46%
33.33%
36.36%
33.33%
42.85%
Operating Margin
-61.53%
-61.53%
-66.66%
-81.81%
-44.44%
-57.14%
Profit Margin
-123.07%
-123.07%
-108.33%
-290.9%
-44.44%
-57.14%
Free Cash Flow Margin
-38.46%
-38.46%
-16.66%
-54.54%
-11.11%
0%
EBITDA
-6
-6
-6
-6
-3
-3
EBITDA Margin
-46.15%
-46.15%
-50%
-54.54%
-33.33%
-42.85%
D&A For EBITDA
2
2
2
3
1
1
EBIT
-8
-8
-8
-9
-4
-4
EBIT Margin
-61.53%
-61.53%
-66.66%
-81.81%
-44.44%
-57.14%
Effective Tax Rate
0%
0%
0%
0%
0%
0%
Follow-Up Questions
What are Novo Integrated Sciences Inc's key financial statements?
According to the latest financial statement (Form-10K), Novo Integrated Sciences Inc has a total asset of $32, Net loss of $-16
What are the key financial ratios for NVOS?
Novo Integrated Sciences Inc's Current ratio is 1.88, has a Net margin is -123.07, sales per share of $0.72.
How is Novo Integrated Sciences Inc's revenue broken down by segment or geography?
Novo Integrated Sciences Inc largest revenue segment is Healthcare Services, at a revenue of 8,297,530 in the most earnings release.For geography, United States is the primary market for Novo Integrated Sciences Inc, at a revenue of 13,294,357.
Is Novo Integrated Sciences Inc profitable?
no, according to the latest financial statements, Novo Integrated Sciences Inc has a net loss of $-16
Does Novo Integrated Sciences Inc have any liabilities?
yes, Novo Integrated Sciences Inc has liability of 17
How many outstanding shares for Novo Integrated Sciences Inc?
Novo Integrated Sciences Inc has a total outstanding shares of 19.05